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Accuracy of continuous central venous oxygen saturation
monitoring in patients undergoing cardiac surgery
Abstract
OBJECTIVE: Continuous assessment of central venous oxygen saturation (S(cevox)O(2)) with the
CeVOX device (Pulsion Medical Systems, Munich, Germany) was evaluated against central venous
oxygen saturation (S(cv)O(2)) determined by co-oximetry. METHODS: In 20 cardiac surgical patients,
a CeVOX fiberoptic probe was introduced into a standard central venous catheter placed in the right
internal jugular vein and advanced 2-3 cm beyond the catheter tip. After in vivo calibration of the probe,
S(cevox)O(2), S(cv)O(2), mixed venous oxygen saturation (S(mv)O(2)) haemoglobin (Hb), body
temperature, heart rate, central venous and mean arterial pressure, and cardiac index were assessed
simultaneously at 30 min intervals during surgery and at 60 min intervals during recovery in the
intensive care unit. Agreement between S(cevox)O(2), and S(cv)O(2) was determined by Bland-Altman
analysis. Simple regression analysis was used to assess the correlation of S(cevox)O(2), and S(cv)O(2)
to Hb, body temperature and haemodynamic parameters. RESULTS: Values of S(cevox)O(2) and
S(cv)O(2) (84 data pairs during surgery and 106 in the intensive care unit) ranged between 45-89% and
43-90%, respectively. Mean bias and limits of agreement of S(cevox)O(2) and S(cv)O(2) were -0.9
(-7.9/+6.1)% during surgery and -1.2 (-10.5/+8.1)% in the intensive care unit. In 37.9% of all measured
data pairs, the difference between S(cevox)O(2) and S(cv)O(2) was beyond clinically acceptable limits
(>/=1 s.d.). Mean bias was significantly influenced by cardiac index. Sensitivity and specificity of
S(cevox)O(2) to detect substantial (>/=1 s.d.) changes in S(cv)O(2) were 89 and 82%, respectively.
CONCLUSIONS: In adult patients during and after cardiac surgery, the current version of the CeVOX
device might not be the tool to replace S(cv)O(2) determined by co-oxymetry, although sensitivity and
specificity of S(cevox)O(2 )to predict substantial changes in S(cv)O(2) were acceptable.
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ABSTRACT 
Objective: Continuous assessment of central venous oxygen saturation (ScevoxO2) with the 
CeVOX device (Pulsion Medical Systems, Munich, Germany) was evaluated against central 
venous oxygen saturation (ScvO2) determined by co-oximetry. 
Methods: In 20 cardiac surgery patients a CeVOX fiberoptic probe was introduced into a 
standard central venous catheter placed in the right internal jugular vein and advanced 2-3 cm 
beyond the catheter tip. After in vivo calibration of the probe, ScevoxO2, ScvO2, mixed venous 
oxygen saturation (SmvO2) haemoglobin (Hb), body temperature, heart rate, central venous and 
mean arterial pressure, and cardiac index were assessed simultaneously at 30-min intervals during 
surgery and at 60-min intervals during recovery in the intensive care unit. Agreement between 
ScevoxO2, and ScvO2 was determined by Bland-Altman analysis. Simple regression analysis was 
used to assess the correlation of ScevoxO2, and ScvO2 to Hb, body temperature and haemodynamic 
parameters. 
Results. Values of ScevoxO2 and ScvO2 (84 data pairs during surgery and 106 in the intensive care 
unit) ranged between 45–89% and 43–90%, respectively. Mean bias and limits of agreement of 
ScevoxO2 and ScvO2 were –0.9 (–7.9 /+6.1) % during surgery and –1.2 (–10.5 / +8.1) % in the 
intensive care unit. In 37.9% of all measured data pairs, the difference between ScevoxO2 and 
ScvO2 was beyond clinically acceptable limits (≥ 1 standard deviation). Mean bias was 
significantly influenced by cardiac index. Sensitivity and specificity of ScevoxO2 to detect 
substantial (≥ 1 standard deviation) changes in ScvO2 were 89 and 82%, respectively. 
Conclusions. The CeVOX device in adult patients during and after cardiac surgery might not be 
the tool to replace ScvO2 determined by co-oxymetry, although sensitivity and specificity of 
ScevoxO2 to predict substantial changes in ScvO2 were acceptable. 
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Introduction 
 
Central venous oxygen saturation (ScvO2) is an important parameter for estimating changes in the 
global oxygen supply-to-demand ratio in various clinical settings [1, 2] and one of the core 
targets for early goal-directed therapy in the treatment of septic shock [3-6]. Recently, the 
Collaborative Study Group in Perioperative ScvO2 Monitoring [7] confirmed the importance of 
low ScvO2 values in predicting an increased risk of perioperative complications in high-risk 
surgical patients. 
Standard means to monitor ScvO2 consist of drawing repeated blood samples from a central 
venous catheter placed in the superior vena cava and measuring ScvO2 by co-oximetry [8]. 
However, this approach is intermittent, increases workload and costs, and results in 
contamination of stopcocks and iatrogenic blood loss. Therefore, reliable techniques for 
continuous monitoring of ScvO2 are desirable. One such technique, based on the principle of near-
infrared spectroscopy [8], is the recently introduced CeVOX system (Pulsion Medical Systems, 
Munich, Germany). To our knowledge, only one experimental study [9] and two clinical 
investigations [10, 11] have been undertaken to evaluate the reliability of the CeVOX system and 
factors influencing its accuracy.  
 
The aim of this study was to evaluate the accuracy of the CeVOX device for continuous 
assessment of central venous oxygen saturation (ScevoxO2) against ScvO2 determined by co-
oximetry during and after cardiac surgery. 
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Methods 
The CeVOX system relies on the principle of near-infrared spectroscopy. Tissue chromophores, 
such as haemoglobin absorb near-infrared light depending on their oxygenation state. Changes in 
chromophore concentrations and oxygenation states, revealed by comparing emitted and detected 
near-infrared light, can therefore be quantified using the modified Lambert-Beer law. 
For the purpose of SCevoxO2 monitoring, light of three wavelengths (660, 805 and 880 nanometer) 
is transmitted through a fiberoptic probe inserted into the distal lumen of a central venous 
catheter placed in the superior vena cava. The tip of the fiberoptic probe must protrude the distal 
end of the catheter by 2-3 cm. It is connected to the optical module of the CeVOX system. Light 
reflected from the haemoglobin in the red blood cells is transmitted back by a second fiberoptic 
line. The sensor in the optical module analyses the reflected light and determines light extinction. 
This information is transferred to the CeVOX system and ScevoxO2 is calculated and displayed on 
the screen.  
 
With ethics committee approval and written, informed consent, 20 patients scheduled for cardiac 
surgery with or without extracorporeal circulation were enrolled in this prospective, non-
randomized, open, monocentre study. Exclusion criteria were refusal to participate in the study, 
hypercoagulation disorders such as factor 5 Leiden disease, contraindications for insertion of a 
pulmonary artery catheter (e.g., surgery of the tricuspid and/or pulmonary valve, haemoptysis, 
thrombi within the right heart or pulmonary artery), contraindications against transesophageal 
echocardiography (e.g., oesophageal varices, gastric ulcers, history of recent acute gastric 
bleeding, narrowing or stenosis of the oesophagus, Zenker diverticle), and presence of an open 
foramen ovale.  
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Premedication consisted of oral flunitrazepam (1.0 to 2.0 mg) the evening before surgery and oral 
midazolam (7.5 to 15 mg ) 45 min before transfer to the operating room. Standard 
instrumentation included a 2-channel ECG (leads II and V5) (Hellige SMU 612 monitor, 
Marquette Hellige Medical Systems, Freiburg i.Br, Germany), pulse oximetry using a finger clip 
(Nellcor Durasensor, Model DS-100A), and continuous arterial blood pressure monitoring  
(Hellige SMU 612 monitor, Marquette Hellige Medical Systems, Freiburg i.Br, Germany) via a 
fluid-filled catheter system (Baxter Healthcare Corporation Cardiovascular Group, Irvine, CA, 
USA) connected to the non dominant radial artery. 
 
Target-controlled intravenous anaesthesia using propofol (plasmaconcentration: 1.5 µg.ml-1 to 2.5 
µg.ml-1), supplemented by bolus injections of fentanyl (3 to 10 µg.kg-1) and pancuronium 
(Organon; 0.1 mg.kg-1), was used for induction of anaesthesia in all patients. Anaesthesia was 
maintained with propofol (1.5 µg.ml-1 to 2.0 µg.ml-1) and remifentanil (0.1 to 0.3 µg.kg-1.min-1). 
After orotracheal intubation, the patient’s lungs were mechanically ventilated (Siemens Servo 
900; Erlangen, Germany) using a volume-controlled mode. 
 
A four-lumen central venous catheter (Arrow International, Reading, PA, USA) and a 7.5 FG 
thermistor-tipped, flow-directed pulmonary artery catheter (IntelliCath; Baxter Healthcare Corp.), 
introduced through an 8.5 FG introducer (Arrow International), were inserted in the right jugular 
vein. The pulmonary artery catheter was connected to a cardiac output computer system (9520A; 
Baxter Healthcare Corp.). Cardiac index (CI) was determined by injecting 10ml of iced saline 
0.9% with a closed injectate system (CO-set; Baxter Healtcare Corp.) Injections were distributed 
randomly throughout the respiratory cycle. Thermodilution curves were displayed on a recorder 
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and accepted as correct if the shape of the curve fulfilled the criteria of Levett and Replogle [12] 
and if the injectate temperature was <10°C.  
 
The CeVOX fiberoptic probe (PV2022-35, Pulsion Medical Systems) was inserted into the distal 
lumen of the central venous catheter. The correct positions of both, the CeVOX fiberoptic probe 
tip and the pulmonary artery catheter tip were verified by transesophageal echocardiography 
before calibration. The CeVOX probe was secured to the distal end of the central venous catheter 
lumen by the integrated luer lock system and connected to the optical module of the CeVOX 
system. In vivo calibration was performed according to the reference manual of the manufacturer. 
Every 30 min during cardiac surgery (t1 to t6) and, after recalibration of the CeVOX system, 
every 60 min after admission to the intensive care unit (ICU) (t7 to t12), central venous and 
mixed venous blood samples were drawn for assessment of ScvO2, SmvO2 and haemoglobin (Hb) 
concentration by co-oximetry. Blood samples were analysed using multi-wavelength 
haemoximetry (ABL 626/620, Radiometer Medical A/S, Akandevey 21, DK-2700 Bronshoj, 
Denmark). Central venous blood samples were drawn from the distal lumen of the central venous 
catheter; the mixed venous blood samples were taken from the pulmonary lumen of the 
pulmonary artery catheter. Simultaneously, ScevoxO2 was recorded, and body temperature, heart 
rate, central venous pressure, mean arterial pressure and CI were documented.  
 
Data analysis 
A power calculation revealed that a sample size of 20 patients would have 80% power to detect a 
difference of ≥ 1 standard deviation between ScvO2 and ScevoxO2 using a paired t-test with a 0.05 
two-sided significance level. Agreement between ScvO2 and ScevoxO2 was determined by Bland-
Altman analysis [13]. Simple regression analysis was used to correlate mean bias of ScvO2 and 
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ScevoxO2 with Hb, body temperature, central venous pressure, mean arterial pressure, and cardiac 
index. Sensitivity and specificity of changes in ScevoxO2 to detect changes in ScvO2 and sensitivity 
and specificity to detect substantial changes (≥1 standard deviation) in ScvO2, were determined. A 
p value of <0.05 was considered significant. In addition, ScevoxO2 and ScvO2 were correlated with 
SmvO2. 
 
 
Results 
 
Patients’ characteristics and haemodynamic data are shown in Tables 1 and 2. Two hundred 
twenty-one data pairs of ScevoxO2 and ScvO2 (115 during surgery and 106 after admission to the 
ICU) were recorded. Thirty-one data pairs were excluded because of detection failure of the 
CeVOX fiberoptic probe due to ambient light when the chest was open. The remaining 190 data 
pairs (84 during surgery and 106 in the ICU) were analysed. ScevoxO2 and ScvO2 values ranged 
between 45–89% and 43–90%, respectively. Mean bias and limits of agreement of ScevoxO2 and 
ScvO2 for all measurements, for measurements during surgery, and for measurements in the ICU 
were –1.1 (–9.5 / +7.3)%, –0.9 (–7.9/ +6.1)% (Fig. 1) and –1.2 (–10.5 / +8.1)%, respectively (Fig. 
2, Table 3). In 37.9% of all data pairs, the difference between ScevoxO2 and ScvO2 was beyond 
clinically acceptable limits (≥ 1 standard deviation). A moderate correlation of the first 
differences between ScevoxO2 and ScvO2 was found (Fig 3) and sensitivity and specificity of 
ScevoxO2 to detect changes in ScvO2 (n = 168 data pairs) was 76 and 85%, respectively (Fig. 3). 
When taking into account only substantial changes in ScvO2 (≥ 1 standard deviation), sensitivity 
increased to 89% with a specificity of 82%. 
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Simple regression analyses revealed that the mean bias of ScevoxO2 and ScvO2 was not influenced 
by Hb (p = 0.33), blood temperature (p = 0.23) or mean arterial pressure (p = 0.94), but an 
association of the bias was found with central venous pressure (p = 0.02) and cardiac index (p = 
0.0002). At low cardiac index values, ScevoxO2 overestimated ScvO2, whereas in the high cardiac 
index range, ScevoxO2 underestimated ScvO2 (Fig. 4). After the CeVOX fiberoptic probe was 
removed, no probe defect or macroscopic visible clot was observed. 
Linear correlation between ScevoxO2 and ScvO2 and between ScevoxO2 and SmvO2  were r2 = 0.41 
and 0.62, respectively. 
 
Discussion 
 
The main findings of this study are that (i) the agreement between ScevoxO2 and ScvO2 was poor; 
(ii) mean bias of ScevoxO2 and ScvO2 was significantly influenced by cardiac index; (iii) 
correlation of first differences between ScevoxO2 and ScvO2 values was only moderate, but 
sensitivity of ScevoxO2 to detect substantial changes in ScvO2 were acceptable; and (iv) only a 
moderate correlation of ScevoxO2 and ScvO2 with SmvO2. was found.  
 
The techniqual prerequisites for continuous measurements of oxygen saturation in the blood 
using spectrophotometry have been available for more than 40 years [14]. Multiple clinical and 
experimental investigations have compared oxygen saturation values derived from fiberoptic 
catheters with those obtained by co-oximetry. Scuderi and colleagues [15] compared three 
pulmonary artery oximetry catheters and reported acceptable agreement with SmvO2 measured by 
co-oximetry with two of the three catheters (95% confidence limits: 2.47% and 3.36%, 
respectively). Burchell and colleagues [16], also comparing fiberoptic SmvO2 values with SmvO2 
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assessed by co-oximetry, interpreted a mean bias of –0.57% and limits of agreement of ±3.76% 
as acceptable. 
The CeVOX system, investigated here is based on three reference light wavelengths and 
characterised by one transmitting and one detecting fiberoptic filament. Advantages of this 
system are that it is easy to handle and does not necessitate additional invasive venous access 
because the disposable 2F fiberoptic catheter can be inserted into a standard central venous line. 
Various lengths (30-48 cm) of the fiberoptic catheter facilitate its use in connection with a variety 
of central venous catheters in adults. In the current study the CeVOX monitoring device for 
continuous assessment of central venous oxygen saturation (ScevoxO2) was compared with central 
venous oxygen saturation (ScvO2) determined by co-oximetry in cardiac surgical patients. This 
investigation revealed that the bias of all ScevoxO2 and ScvO2 values was good, but the limits of 
agreement were unacceptably high. 
Recently, Muller and colleagues [10] investigated the CeVOX system in three cyanotic infants 
undergoing modifications of the stage 1 Norwood procedure. They reported that the technique is 
feasible in infants, although the number of measured data pairs was small and, at ScvO2 values 
≤50%, the mean bias and limits of agreement of ScevoxO2 and ScvO2 were unacceptable. 
Most recently, Molnar and colleagues [11] performed a multicentre study and reported good 
comparability of ScevoxO2 and ScvO2 in a heterogeneous group of critically ill patients, although 
the limits of agreement were high (–13.2 and 12.5%). Furthermore, in 12 of 53 patients (>20%) 
they found a difference of ≥10% at any time point between ScevoxO2 and ScvO2 values determined 
by co-oximetry. This was confirmed in the current study, were the difference between ScevoxO2 
and ScvO2 was beyond clinically acceptable limits in 37.9% of all data pairs.  
Hofer and colleagues [17] investigated the CeVOX device in ASA III patients undergoing 
elective off-pump coronary artery bypass surgery. They reported that continuous ScvO2 
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assessment using CeVOX was reliable. In their study, the mean bias of ScevoxO2 and ScvO2 was 
good, but the limits of agreement during surgery and in the ICU were as high as in the present 
study (±8% and ±12%, respectively). Similar to our results, they also found less agreement 
between ScevoxO2 and ScvO2 after surgery than during surgery. It could be hypothesized that the 
probability of inadequate volume load and consecutive vein wall artefacts of the fiberoptic probe 
is higher in the ICU. Indeed, in our study the mean central venous pressure found in the ICU was 
lower than during surgery at constant positive end-expiratory pressure. Another possible 
explanation for the reduced agreement of the two methods after surgery may be the time-related 
higher probability of clot formations at the tip of the fiberoptic catheter during recovery in the 
ICU. Hypercoagulation states after cardiac surgery with or without cardiopulmonary bypass are 
well known [18, 19]. We cannot definitively exclude this explanation, although no visible clots 
were found at the tips of the CeVOX fiberoptic probes after removal.  
 
Interestingly, the Bland-Altman analysis of the data pairs collected during and after surgery 
suggests a nearly linear dependence of the mean bias of ScevoxO2 and ScvO2 on ScvO2, possibly 
indicating a systematic error in the CeVOX algorithm. Most recently Huber and colleagues [9] 
compared oxygen saturation values obtained with a 2 French CeVOX fiberoptic probe and a 4 
French Edwards oximetry catheter against values measured by co-oximetry in an in vitro setting 
and demonstrated overestimation at low and underestimation at high oxygen saturations. They 
recommended repeated recalibration to reduce the drift of fiberoptic oxymetry values. In an own 
most recently published in vitro study [20] these findings were confirmed. One possible reason 
for the suggested linear dependency may be a systematic error in the calibration factor (Cal-
Value) of the CeVOX system, recommended by the manufacturer. But this hypothesis remains to 
be determined. 
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Additionally, the mean bias of ScevoxO2 and ScvO2 in the present study was significantly 
influenced by the Cardiac index: ScevoxO2 overestimated ScvO2 at low CI values and 
underestimated it at high values.  
First differences between ScevoxO2 and ScvO2 found in the current investigation showed only a 
moderate correlation, indicating a considerable number of significant changes in opposite 
direction. Only sensitivity and specificity of ScevoxO2 to detect substantial changes in ScvO2 were 
acceptable (85 and 82%, respectively).  
 
In agreement with previous investigations [21-23], neither ScevoxO2 nor ScvO2 reliably reflected 
SmvO2. The first differences between ScvO2 and SmvO2 were only moderately correlated, and 
changes in ScvO2 only roughly tracked changes in SmvO2 (data not shown). Correlation of the first 
differences between ScevoxO2 and SmvO2 was even worse.  
 
In conclusion, the current version of the CeVOX device might not be the tool to replace ScvO2 
determined by co-oxymetry. Even though the sensitivity and specificity of ScevoxO2 to detect 
substantial changes in ScvO2 are acceptable, the current version of the CeVOX device cannot be 
recommended for clinical application in high risk surgery. Considering the importance of 
continuous central venous oxygen saturation monitoring, efforts should be made to improve the 
reliability of the CeVOX device. 
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Figure Legends 
 
Fig. 1. Agreement between ScevoxO2 and ScvO2 of 84 data pairs during surgery. Mean bias, –0.9 
%; LOA, –7.9 / +6.1%. 
 
Fig. 2. Agreement between ScevoxO2 and ScvO2 of 106 data pairs during recovery in the ICU. 
Mean bias, –1.2%; LOA, –10.5 / +8.13%. 
 
Fig. 3. First differences of ScevoxO2 (diff ScevoxO2) and ScvO2 (diff ScvO2) [in %] with R2 = 0.464, p 
< 0.0001). 
 
Fig. 4. Influence of cardiac index (L.min-1.m-2) on mean bias of ScevoxO2 and ScvO2 (%). 
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Table 1 Patients’ characteristics. Values are expressed as number or median (range). 
 
No. of patients   20   
Sex, M:F    12 : 8 
Age, years    71 (41 – 84) 
Body mass index, kg.m-2  27.8 (18.8 – 34.4) 
Body surface area, m2   1.87 (1.5 – 2.4) 
Preoperative LV-EF, %  60 (10 – 78) 
Surgery, no. of patients 
 OPCAB    8 
 CABG     2 
 Valve     7 
 Valve + CABG   3 
__________________________________________________________________________ 
 
Abbreviations: LV-EF, left ventricular ejection fraction; OPCAB, off-pump coronary artery 
bypass; CABG, coronary artery bypass graft; valve + CABG, combined valve and coronary 
artery bypass graft surgery.  
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 Table 2 Haemodynamic characteristics. Values are expressed as median (range). 
 
SmvO2 , %    72.15 (50 - 89) 
Blood temperature, °C   36.6 (31.0 - 38.6) 
Pulse rate, bpm   83 (40 - 110) 
Mean arterial pressure, mm Hg 71 (53 – 95) 
Central venous pressure, mm Hg 9 (0 – 25) 
Cardiac index, liter.min-1.m-2  2.6 (1.0 - 4.5) 
__________________________________________________________________________ 
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Table 3 Bland-Altman analysis of ScevoxO2 and ScvO2 for all data, .data pairs during surgery and 
data in the ICU 
 
Data pairs    n  Mean bias LOA   
__________________________________________ _______________________________________________________ 
ScevoxO2–ScvO2 (all data)  190  –1.1  –9.5   / +7.3  
ScevoxO2–ScvO2 (surgery)  83  –0.9  –7.9   / +6.1  
ScevoxO2–ScvO2 (ICU)    107  –1.2  –10.5 / +8.1  
 
Abbreviations: ScevoxO2, continuous measured central venous oxygen saturation by the CeVOX 
device; ScvO2, central venous oxygen saturation; LOA, limits of agreement. 
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Figures 
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Fig. 2 
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Fig 3 
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Fig. 4 
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